Dry Eye Rescue Is Offering Friends Of MDA A 20% Discount On All Products To Help With Your Eye Conditions
Click Here To Save Now
Nov 7, 2024
The FDA granted investigational drug clearance to HG202, a CRISPR/Cas13Y RNA-editing therapy for neovascular age-related macular degeneration, according to a press release from HuidaGene. According to the release, HG202 is the…
Nov 6, 2024
Author(s): David Hutton Joanne F. Shen, MD, director of the dry eye clinic at Mayo Clinic’s campus in Phoenix, Arizona, and a research team studied 35 patients treated with IPL/MGX.…
Nov 4, 2024
October 29, 2024, By Cristina M. Schnider, OD, MSc, MBA, FAAO Many people know that invisible UV light can cause a sunburn and contribute to skin aging and skin cancer, but…
Oct 29, 2024
October 28, 2024 Key takeaways: Eating 2 oz. of pistachios daily for 12 weeks significantly increased macular pigment optical density. Serum lutein concentration also improved in the group that consumed…
Oct 28, 2024
Specific genes associated with inherited retinal dystrophies (IRDs) also influence refractive errors (RE), such as myopia and hyperopia, according to a study that found these genetic patterns vary widely, suggesting…
Oct 28, 2024
October 25, 2024 ew study about Geographic Atrophy By Jordana Joy, Associate Editor The data showed a 15.3% reduction in the GA lesion growth rate versus placebo from 6 to 24…
Oct 23, 2024
SAVE THE DATE: Tuesday December 3rd, 2024 #GivingTuesday—a movement to create a global day of giving Today. We need your help to help those Living with Macular Degeneration On Tuesday,…
Oct 22, 2024
by: Lynda Charters Listen Key Takeaways Photobiomodulation may reduce visual loss and disease progression in dry AMD, offering a new treatment option for patients. The study showed significant visual acuity…
Oct 7, 2024
A new study shows metformin may help prevent vision loss associated with age-related macular degeneration. News Published: October 7, 2024 Original story from the University of Chicago Age-related macular degeneration…
Sep 23, 2024
September 19, 2024 By David Hutton Oral gildeuretinol demonstrated a clinically meaningful reduction in the geographic atrophy lesion growth rate at 24 months, supporting additional clinical development. SAGA topline data has…
Sep 19, 2024
The agency sounds alarm that products still may contain amniotic fluid by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today September 17, 2024 The FDA has sent another letter — this…
Sep 16, 2024
By Julia Ries | Fact-checked by Davi Sherman | Published September 13, 2024 Key Takeaways Certain foods like chocolate, greasy snacks, and spicy dishes can disrupt sleep due to their effects on digestion and caffeine content.…
Sep 12, 2024
A look at developments that have propelled us forward and those still to come for eye care. by: Julie Poteet, OD, MS, CNS, FOWNS At A Glance The increasing prevalence…
Sep 11, 2024
Contrast sensitivity impairment showed the strongest relationship by Judy George, Deputy Managing Editor, MedPage TodaySeptember 5, 2024 Last Updated September 6, 2024 Key Takeaways Up to 19% of prevalent dementia cases may be…
Sep 9, 2024
By David Hutton The Phase 1 trial is a multicenter, open-label, dose-escalation safety clinical trial, with 18 subjects, who each have received a single periocular injection of AIV007 AiViva Biopharma Inc…
Aug 21, 2024
August 20, 2024, By Jordana Joy, Associate Editor The alert follows a warning letter issued by the US FDA to a company that manufactures eye drops that claim to change eye…
Aug 15, 2024
By Kate YoungFact checked by Heather Biele Key takeaways: Prevalence of AMD-related blindness decreased globally from 2000 to 2020. Older age is associated with greater prevalence of AMD-related vision loss.…
Aug 12, 2024
New Press Release The U.S. Food and Drug Administration (FDA) has approved Sandoz biosimilar Enzeevu™ (aflibercept-abzv) 2 mg vial kit and pre-filled syringe for intravitreal injection. Enzeevu is indicated to…
Aug 12, 2024
By Lisa Marie Basile | Fact-checked by Davi Sherman | Published July 16, 2024 Key Takeaways A new cohort study published in JAMA Network Open analyzed data from nearly 400,000 participants over 20 years and found that the use…
Aug 9, 2024
New Study Ocular Therapeutix obtained FDA support to use the phase 3 SOL-R trial as the next step in the regulatory process for Axpaxli, according to a press release. The FDA…
Aug 6, 2024
by: Steven Ferrucci, OD, FAAO Key takeaways: The AREDS2 supplement slowed the expansion of geographic atrophy toward the fovea by approximately 55% over 3 years in patients with dry AMD.…
Jul 28, 2024
By Julia Ries | Fact-checked by Davi Sherman | Published July 25, 2024 Key Takeaways The lion’s mane mushroom is gaining popularity for its potential health benefits, particularly in supporting memory and preventing cognitive decline. Mushrooms, including…
Jul 26, 2024
The Stress Response Your muscles tense, your heart races and your breath comes faster — we all know what stress feels like. The “fight or flight” response is behind it:…
Jul 25, 2024
Case-control study shows reduction in new-onset GA, particularly in nondiabetic patients by Charles Bankhead, Senior Editor, MedPage TodayJuly 22, 2024 STOCKHOLM — The risk of developing geographic atrophy (GA) declined significantly in…
Jul 8, 2024
Key takeaways: The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. The syringe will be available in the U.S. later this year.…
Jul 1, 2024
KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Joe Luvisi, MD, discusses the use of AI to predict response to anti-VEGF therapy in diabetic macular edema. Luvisi and…
Jun 25, 2024
by: Walter O. Whitley OD, MBA, FAAO Exploring strategies for effective management of a multifaceted condition Dry eye disease (DED) is a chronic and often progressive condition that can be…
Jun 25, 2024
By: David Hutton Positive data from the GALE long-term extension study showed patients developed fewer new scotomatous points with 36 months of both continuous monthly and every-other-month treatment. A study…
Jun 11, 2024
Key takeaways: The Abbott Libre Rio was cleared for adults with type 2 diabetes who do not use insulin. The FDA cleared the Abbott Lingo for adults who want to…
Jun 10, 2024
June 10, 2024 SYFOVRE is the only approved GA treatment to demonstrate a visual function benefit in a prespecified endpoint Data presented at the Clinical Trials at the Summit Meeting…